Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Youyang Shi"'
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 14, Iss 10, Pp 100977- (2024)
Trastuzumab has improved survival rates in human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC), but drug resistance leads to treatment failure. Natural killer (NK) cell-mediated antibody-dependent cell cytotoxicity (ADCC) repr
Externí odkaz:
https://doaj.org/article/6b3649ef1f604c7da224a314d7c2ae85
Autor:
Rongzhou Wu, Tingting Wu, Qiaoyu Wang, Youyang Shi, Qianqian Dong, Xing Rong, Meiting Chen, Zhiyu He, Yu Fu, Lei Liu, Shuai Shao, Xueqiang Guan, Chunxiang Zhang
Publikováno v:
MedComm, Vol 5, Iss 7, Pp n/a-n/a (2024)
Abstract Long non‐coding RNA RP11‐64B16.4 (myocardial infarction protection‐related lncRNA [MIPRL]) is among the most abundant and the most upregulated lncRNAs in ischemic human hearts. However, its role in ischemic heart disease is unknown. We
Externí odkaz:
https://doaj.org/article/93936d2cc2774b9da8d7ede0c3855952
Autor:
Zhanyang Luo, Bukun Zhu, Hong Xu, Lixin Chen, Xiaoyun Song, Yu Wang, Rui Wang, Jinzhou Zheng, Yunhua Qiu, Jianfeng Yang, Youyang Shi
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundOlaparib has been proven for the treatment of metastatic castration-resistant prostate cancer (mCRPC). This meta-analysis aims to comprehensively evaluate the efficacy and safety of the combination of olaparib and abiraterone in patients wi
Externí odkaz:
https://doaj.org/article/17e3e7cd2e354f1bb4a8f4a9f60c505e
Autor:
Xiaojuan Yang, Rui Yang, Yang Zhang, Youyang Shi, Mei Ma, Feifei Li, Ying Xie, Xianghui Han, Sheng Liu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 165, Iss , Pp 115164- (2023)
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by high invasion and metastasis rates. Xian-Ling-Lian-Xia formula (XLLX) is a traditional Chinese medicine prescription widely used in China for treating TNB
Externí odkaz:
https://doaj.org/article/77152e8fc7a44c628e5be61387ad871c
Autor:
Youyang Shi MD, PhD, Yuanyuan Wu MD, Man Shen MD, PhD, Jianfeng Yang MD, PhD, Yuenong Qin MD, Sheng Liu MD, PhD, Chenping Sun MD, PhD
Publikováno v:
Integrative Cancer Therapies, Vol 22 (2023)
Doxorubicin (Dox) is a first-line chemotherapeutic agent applied in cancer treatment. Its long-term anticancer efficacy is restricted mainly due to its subsequent cardiotoxicity for patients. Platycodon grandiflorum (PG), an important traditional Chi
Externí odkaz:
https://doaj.org/article/4e426797d33544d7b1ef11b6652bca67
Autor:
Feifei Li, Youyang Shi, Yang Zhang, Xiaojuan Yang, Yi Wang, Kexin Jiang, Ciyi Hua, Chunyu Wu, Chenping Sun, Yuenong Qin, Sheng Liu
Publikováno v:
Chinese Medicine, Vol 17, Iss 1, Pp 1-20 (2022)
Abstract Background Xian-ling-lian-xia-fang (XLLXF), a Chinese medicine decoction, is widely used in the treatment of triple negative breast cancer (TNBC). However, the underlying mechanism of XLLXF in TNBC treatment has not been totally elucidated.
Externí odkaz:
https://doaj.org/article/5c532938ed9a49e2bec7782f48ecc8b2
Autor:
Jianfeng Yang, Jin Xu, Qian Gao, Fan Wu, Wei Han, Chao Yu, Youyang Shi, Yunhua Qiu, Yuanbiao Chen, Xiqiu Zhou
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe incidence and mortality of bladder cancer (BCa) are increasing, while the existing diagnostic methods have limitations. Therefore, for early detection and response prediction, it is crucial to improve the prognosis and treatment strateg
Externí odkaz:
https://doaj.org/article/feb142ac0c0f4ebeac7afb083ae80bfc
Autor:
Feifei Li, Youyang Shi, Xiaojuan Yang, Zhanyang Luo, Guangtao Zhang, Kui Yu, Feng Li, Lixin Chen, Youkang Zhao, Ying Xie, Yuanyuan Wu, Jianfeng Yang, Xiqiu Zhou, Sheng Liu
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2022)
Background: Breast cancer (BC) is the leading cause of cancer-related deaths among women worldwide. The application of advanced technology has promoted accurate diagnosis and treatment of cancer. Anhydroicaritin (AHI) is a flavonoid with therapeutic
Externí odkaz:
https://doaj.org/article/009c7ac038a643ccbc62c03b5d285b09
Autor:
Youyang Shi, Feifei Li, Man Shen, Chenpin Sun, Wei Hao, Chunyu Wu, Ying Xie, Shuai Zhang, Hongzhi Gao, Jianfeng Yang, Zhongyan Zhou, Dongwen Gao, Yuenong Qin, Xianghui Han, Sheng Liu
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Background: Doxorubicin (Dox) is one of the most effective chemotherapy agents used in the treatment of solid tumors and hematological malignancies. However, it causes dose-related cardiotoxicity that may lead to heart failure in patients. Luteolin (
Externí odkaz:
https://doaj.org/article/8737b41ba0904b3695f895d1aa405b76
Autor:
Rui Yang, Ying Xie, Qiong Li, Yiyi Ye, Youyang Shi, Xiangdong Zhao, Chunyu Wu, Yiyun Xu, Rui Wang, Yang Zhang, Xiaojuan Yang, Xianghui Han, Sheng Liu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 141, Iss , Pp 111883- (2021)
Lung metastasis of Triple-negative breast cancer (TNBC) causes severe breath-related events and poor prognosis. Ruyiping (RYP), a traditional Chinese medicine prescription, is used to treat breast cancer lung metastasis in clinical practice. This stu
Externí odkaz:
https://doaj.org/article/dfceef2b11b9411bbd19a7e6dea9de9f